Loading NewKerala.com...

Alzheimer's cases in 8 major markets to reach 22.51 million in 2033: Report

IANS January 6, 2025 296 views

A new report from GlobalData highlights a concerning trend in Alzheimer's disease, projecting a substantial increase in cases across eight major global markets. The research reveals that women are disproportionately affected, with 73% of cases primarily impacting older adults aged 75 and above. China is expected to have the highest number of cases at 10.4 million by 2033, underscoring the growing global health challenge. The report emphasizes the critical need for comprehensive research, treatment strategies, and support systems to address this escalating healthcare issue.

"Mortality remains a significant concern for individuals living with AD and their families." - Antara Bhattacharya
Alzheimer's cases in 8 major markets to reach 22.51 million in 2033: Report
New Delhi, Jan 6: The prevalent cases of Alzheimer’s disease (AD) in the eight major markets globally are set to register an annual growth rate (AGR) of 4.08 per cent from 15.99 million in 2023 to 22.51 million in 2033, according to a report on Monday.

Key Points

1

China to lead with 10.4 million Alzheimer's cases in 2033

2

Women comprise 73% of total prevalent cases

3

Older adults 75+ represent 79% of Alzheimer's patients

China will have the highest number of total prevalent cases of AD (by DSM-IV criteria) at 10.4 million cases, whereas Spain will have the lowest number at 0.62 million cases in 2033, according to the report by GlobalData, a leading data and analytics company.

“In 2023, women were more affected than men, accounting for approximately 73 per cent of the total prevalent cases,” said Antara Bhattacharya, associate project manager, epidemiology team.

Older adults in ages 75 years and above accounted for almost 79 per cent of the total prevalent cases of AD in the eight major markets in 2023, while comparatively younger adults in ages 65-74 years accounted for approximately 21 per cent of the cases.

The report estimated that in 2023, approximately 55 per cent of total prevalent cases of AD were mild, whereas only 16 per cent of total prevalent cases of AD were severe.

“Mortality remains a significant concern for individuals living with AD and their families. Efforts to prevent or delay the disease are expected to have a profound impact on long-term outcomes, as the value of treatment will largely depend on a therapy’s effectiveness in reducing morbidity and extending life expectancy,” said Bhattacharya.

Extensive research can improve our understanding of the crucial relationship between AD and mortality.

“Moreover, the treatment for AD requires a multifaceted approach that integrates medical interventions, lifestyle modifications, ongoing support, along with clinical trials, and follow-up care,” said the report.

Tags:
You May Like!